In T-DLBCL, higher content of CD3+ TILs in general (Figure 2A), as well as higher proportions of both CTLs and CD4+ TILs, has been demonstrated to be associated with favorable outcomes [23]. Here, CD4 is linked to diffuse large B-cell lymphoma.